Press release of HanAll Pharma on success of Phase-I human clinical trials of our compound (ATH 399A). A ray of hope for Parkinson patients!
@LtGenGurmit @pushkardhami @HigherE07868099 @PMOIndia @narendramodi @ugc_india @IndiaDST